Literature DB >> 11096744

Delirium and Agitation.

.   

Abstract

Delirium is a syndrome of altered state of consciousness and global cognitive impairment with diverse causes. It is common in the medically or surgically compromised patient and is associated with significant morbidity and mortality. The primary goal of treatment is to identify and correct the underlying cause of the delirium. Treatment includes protecting the patient from accidental self-harm, initiating pharmacotherapy to manage disruptive and dangerous behavior and symptoms of psychosis, and providing supportive and educational therapy for the patient and family. Physical restraints may need to be used for patients at immediate risk of injuring themselves or someone else until pharmacologic management can be initiated. Antipsychotics such as haloperidol with or without lorazepam are the treatment of choice. Environmental factors that may exacerbate delirium also need to be controlled. Patients should be reoriented and may benefit by having familiar or favorite objects present, such as family pictures. Sleep-wake disturbances must be corrected, and visual and auditory impairments must be addressed. Because family members can have a calming effect, provide frequent reorientation, and give the patient a sense of safety, family should be encouraged to be present if at all possible.

Entities:  

Year:  2000        PMID: 11096744     DOI: 10.1007/s11940-000-0015-0

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.972


  17 in total

Review 1.  The Delirium Rating Scale. Its use in consultation-liaison research.

Authors:  P T Trzepacz
Journal:  Psychosomatics       Date:  1999 May-Jun       Impact factor: 2.386

2.  Early diagnosis of delirium after cardiac surgery.

Authors:  I Koolhoven; M R Tjon-A-Tsien; R C van der Mast
Journal:  Gen Hosp Psychiatry       Date:  1996-11       Impact factor: 3.238

Review 3.  Using electroconvulsive therapy for patients with neurological disease.

Authors:  S L Dubovsky
Journal:  Hosp Community Psychiatry       Date:  1986-08

4.  High-dose intravenous haloperidol for agitated delirium following lung transplantation.

Authors:  J L Levenson
Journal:  Psychosomatics       Date:  1995 Jan-Feb       Impact factor: 2.386

5.  Use of risperidone in delirium: case reports.

Authors:  A Sipahimalani; P S Masand
Journal:  Ann Clin Psychiatry       Date:  1997-06       Impact factor: 1.567

Review 6.  Delirium. Advances in diagnosis, pathophysiology, and treatment.

Authors:  P T Trzepacz
Journal:  Psychiatr Clin North Am       Date:  1996-09

7.  A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients.

Authors:  W Breitbart; R Marotta; M M Platt; H Weisman; M Derevenco; C Grau; K Corbera; S Raymond; S Lund; P Jacobson
Journal:  Am J Psychiatry       Date:  1996-02       Impact factor: 18.112

8.  Continuous infusion of haloperidol controls agitation in critically ill patients.

Authors:  R R Riker; G L Fraser; P M Cox
Journal:  Crit Care Med       Date:  1994-03       Impact factor: 7.598

9.  Increasing the recognition of delirium in elderly patients.

Authors:  K Rockwood; S Cosway; P Stolee; D Kydd; D Carver; P Jarrett; B O'Brien
Journal:  J Am Geriatr Soc       Date:  1994-03       Impact factor: 5.562

10.  The use of environmental strategies and psychotropic medication in the management of delirium.

Authors:  D J Meagher; D O'Hanlon; E O'Mahony; P R Casey
Journal:  Br J Psychiatry       Date:  1996-04       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.